(Q37754865)

22 August 2017

Statins as emerging treatments for asthma and chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

22 August 2017

0 references

1 reference

Garry M Walsh

1

1 reference

22 August 2017

1 June 2008

1 reference

Expert Review of Respiratory Medicine

22 August 2017

1 reference

22 August 2017

2

1 reference

22 August 2017

329-335

1 reference

22 August 2017

3

1 reference

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

22 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Structural and inflammatory changes in COPD: a comparison with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Drug development for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Isoprenoid metabolism and the pleiotropic effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Floating the raft hypothesis for immune receptors: access to rafts controls receptor signaling and trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Statin-induced immunomodulatory effects on human T cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Differential effects of statins on relevant functions of human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Statin-induced apoptosis and skeletal myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Role of HMG-CoA Reductase Inhibitors in Neurological Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Potential therapeutic role for statins in respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Control of eosinophil toxicity in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Increased TGF-beta2 in severe asthma with eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Cardiovascular risk in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Editorial: A new decade, a new editor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Inhibition of VEGF receptors causes lung cell apoptosis and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Corpse clearance defines the meaning of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Phagocytosis: elegant complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Recognition ligands on apoptotic cells: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Clearance of apoptotic and necrotic cells and its immunological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Antiinflammatory Roles of Peroxisome Proliferator–activated Receptor γ in Human Alveolar Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Statin use is associated with reduced mortality in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Should treatment of sepsis include statins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.3.329

21 January 2018

Identifiers

DOI

10.1586/17476348.2.3.329

1 reference

22 August 2017

1 reference

PubMed ID

20477197